A Case Report of Severe Delirium after Amantadine Withdrawal
A Case Report of Severe Delirium after Amantadine Withdrawal
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland: S. Karger AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: S. Karger AG
Subjects
More information
Scope and Contents
Contents
Amantadine is frequently used in addition to dopaminergic substances like dopamine agonists or L-Dopa in advanced Parkinson disease (PD). However, adverse effects like hallucinations limit its use. PD patients developing severe psychotic symptoms upon treatment with either dopaminergic substances and/or amantadine need to stop intake of any psychot...
Alternative Titles
Full title
A Case Report of Severe Delirium after Amantadine Withdrawal
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1990561439
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1990561439
Other Identifiers
ISSN
1662-680X
E-ISSN
1662-680X
DOI
10.1159/000460814
